A recent study suggests that people who come off blockbuster weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise plans.
Research printed in a major medical journal points out that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month after stopping.
"Users purchasing these medications must be informed of the potential of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of recovery implies a reversion to original weight in about one and a half years.
Comparing Therapies
The study, which reviewed dozens of trials involving thousands of participants, compared the effects of these new drugs with older methods.
The team note that people who lose weight through dieting typically have a slower weight regain—around 0.1 kg a month—post-intervention.
Understanding the Rapid Rebound
Doctors suggest the mechanism of the drugs accounts for the heightened regain.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 levels far above than the body's typical production may cause the system to produce less of its own natural hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication leads to hunger is uncontrolled, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, due to the significant potential of weight regain, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the chronic character of excess weight," similar to managing conditions like diabetes.
User Experiences
Users who have stopped the medication describe a powerful return of cravings.
"I experienced something activating and you're instantly extremely hungry," described one woman.
This challenge is exacerbated if users have not established permanent lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates show that millions of people in the UK have used these injections in the past year, with desire being substantial.
- Use is higher among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers caution that while these medications are potent agents for weight loss, they are not a magic solution and lasting health benefits hinges on ongoing lifestyle management.
